156 related articles for article (PubMed ID: 19092280)
1. Systemic chemotherapy of hepatocellular carcinoma--Korean experience.
Lee HC
Oncology; 2008; 75 Suppl 1():114-8. PubMed ID: 19092280
[TBL] [Abstract][Full Text] [Related]
2. Systemic therapy of hepatocellular carcinoma: are we making progress?
Roxburgh P; Evans TR
Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapies in hepatocellular carcinoma.
Wörns MA; Weinmann A; Schuchmann M; Galle PR
Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma].
Kondo S; Ueno H; Morizane C; Okusaka T
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
[TBL] [Abstract][Full Text] [Related]
5. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Zhu AX
Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in hepatocellular carcinoma.
Okada S
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy for liver cancer: updated review in 2012.
Kudo M
Curr Cancer Drug Targets; 2012 Nov; 12(9):1062-72. PubMed ID: 22920326
[TBL] [Abstract][Full Text] [Related]
8. Novel advancements in the management of hepatocellular carcinoma in 2008.
Llovet JM; Bruix J
J Hepatol; 2008; 48 Suppl 1():S20-37. PubMed ID: 18304676
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
Rimassa L; Santoro A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatments for resectable hepatocellular carcinoma.
Ishii H; Yamamoto J; Ikari T
J Hepatobiliary Pancreat Surg; 2008; 15(5):459-62. PubMed ID: 18836796
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
Zender L; Kubicka S
Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
[TBL] [Abstract][Full Text] [Related]
12. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for hepatocellular carcinoma.
Skelton MR; O'Neil B
Clin Adv Hematol Oncol; 2008 Mar; 6(3):209-18. PubMed ID: 18391920
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
[TBL] [Abstract][Full Text] [Related]
15. Improved chemotherapy for hepatocellular carcinoma.
Cao H; Phan H; Yang LX
Anticancer Res; 2012 Apr; 32(4):1379-86. PubMed ID: 22493374
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors in development for hepatocellular carcinoma.
Wörns MA; Galle PR
Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.
Witjes CD; Verhoef C; Verheul HM; Eskens FA
Neth J Med; 2009 Mar; 67(3):86-90. PubMed ID: 19307678
[TBL] [Abstract][Full Text] [Related]
18. Growth factors as therapeutic targets in HCC.
Furuse J
Crit Rev Oncol Hematol; 2008 Jul; 67(1):8-15. PubMed ID: 18434184
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatocellular carcinoma].
del Val Antonana A; Ortiz Polo I; López Serrano A; Moreno-Osset E
An Med Interna; 2002 Oct; 19(10):533-8. PubMed ID: 12481499
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for hepatocellular carcinoma.
Sandhu DS; Tharayil VS; Lai JP; Roberts LR
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]